Soichi Iritani

15 papers · 322 indexed citations

Immediate Impact

66 hit

Sub-graph 1 of 22

Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD

2025 Hit

Metabolic Dysfunction–Associated Steatotic Liver Disease

2025 Hit

1 intermediate paper

Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease

2020

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Soichi Iritani	195	115	99	74	72	15	322
Elia Gigante	109 0.6×	160 1.4×	121 1.2×	126 1.7×	39 0.5×	23	355
Paola Begini	135 0.7×	135 1.2×	123 1.2×	27 0.4×	53 0.7×	23	293
Shunji Koya	154 0.8×	83 0.7×	81 0.8×	21 0.3×	42 0.6×	19	243
Kazuhito Sakata	86 0.4×	122 1.1×	96 1.0×	136 1.8×	30 0.4×	17	318
Shirin Feshtali	149 0.8×	118 1.0×	107 1.1×	81 1.1×	9 0.1×	24	352
Hidetaro Ueki	77 0.4×	174 1.5×	165 1.7×	64 0.9×	10 0.1×	11	300
Joerg Boecker	88 0.5×	100 0.9×	79 0.8×	220 3.0×	11 0.2×	19	343
Fatih Saygılı	104 0.5×	24 0.2×	43 0.4×	123 1.7×	44 0.6×	18	284
Hidekazu Nakagawara	50 0.3×	188 1.6×	87 0.9×	135 1.8×	21 0.3×	11	329
Faïza Khemissa	86 0.4×	45 0.4×	20 0.2×	46 0.6×	47 0.7×	23	256

Loading papers...